Cargando…
晚期非小细胞肺癌免疫治疗进展
Immunotherapy, in particular immune checkpoint inhibitors, has significantly improved the survival outcomes of advanced lung cancer patients and changed the treatment mode of lung cancer. In this article, we reviewed the mechanism of immunotherapy, the clinical trials that changed treatment guidelin...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936086/ https://www.ncbi.nlm.nih.gov/pubmed/33508897 http://dx.doi.org/10.3779/j.issn.1009-3419.2021.102.06 |
| _version_ | 1783661130117283840 |
|---|---|
| collection | PubMed |
| description | Immunotherapy, in particular immune checkpoint inhibitors, has significantly improved the survival outcomes of advanced lung cancer patients and changed the treatment mode of lung cancer. In this article, we reviewed the mechanism of immunotherapy, the clinical trials that changed treatment guidelines, the important biomarkers, immune-related adverse events, and descripted the future of immunotherapy of advanced non-small cell lung cancer. |
| format | Online Article Text |
| id | pubmed-7936086 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | 中国肺癌杂志编辑部 |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79360862021-03-19 晚期非小细胞肺癌免疫治疗进展 Zhongguo Fei Ai Za Zhi 综述 Immunotherapy, in particular immune checkpoint inhibitors, has significantly improved the survival outcomes of advanced lung cancer patients and changed the treatment mode of lung cancer. In this article, we reviewed the mechanism of immunotherapy, the clinical trials that changed treatment guidelines, the important biomarkers, immune-related adverse events, and descripted the future of immunotherapy of advanced non-small cell lung cancer. 中国肺癌杂志编辑部 2021-02-20 /pmc/articles/PMC7936086/ /pubmed/33508897 http://dx.doi.org/10.3779/j.issn.1009-3419.2021.102.06 Text en 版权所有©《中国肺癌杂志》编辑部2021 This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/. |
| spellingShingle | 综述 晚期非小细胞肺癌免疫治疗进展 |
| title | 晚期非小细胞肺癌免疫治疗进展 |
| title_full | 晚期非小细胞肺癌免疫治疗进展 |
| title_fullStr | 晚期非小细胞肺癌免疫治疗进展 |
| title_full_unstemmed | 晚期非小细胞肺癌免疫治疗进展 |
| title_short | 晚期非小细胞肺癌免疫治疗进展 |
| title_sort | 晚期非小细胞肺癌免疫治疗进展 |
| topic | 综述 |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936086/ https://www.ncbi.nlm.nih.gov/pubmed/33508897 http://dx.doi.org/10.3779/j.issn.1009-3419.2021.102.06 |
| work_keys_str_mv | AT wǎnqīfēixiǎoxìbāofèiáimiǎnyìzhìliáojìnzhǎn AT wǎnqīfēixiǎoxìbāofèiáimiǎnyìzhìliáojìnzhǎn |